IanRabinowitzMD

Oncology • Albuquerque, NM

Professor, Internal Medicine, University of New Mexico School of Medicine

Join to view full profile

Dr. Rabinowitz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Rabinowitz's full profile

Already have an account?

Office
1201 Camino de Salud NE
Albuquerque, NM 87102
Phone+1 505-272-4946

Fax+1 505-925-0100
Is this information wrong?

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1989 - 1992
Vanderbilt University Medical CenterResidency, Internal Medicine, 1986 - 1989
University of the WitwatersrandClass of 1984

Certifications & Licensure

NM State Medical License 1997 - 2025
TN State Medical License 1989 - 1992
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2014

Clinical Trials

Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Start of enrollment: 2004 Jan 01
Completed
Phase 3
Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid Tumors Start of enrollment: 2004 Apr 01
Completed
Phase 1
Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy Regimen Start of enrollment: 2004 Apr 01
Completed
Not Applicable
A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail Gleevec Start of enrollment: 2004 Apr 01
Completed
Phase 2
Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma Start of enrollment: 2000 Sep 01
Completed
Phase 2
INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma. Start of enrollment: 2002 Aug 01
Completed
Phase 2
Physiological Biomarkers of Cancer Treatment Related Fatigue in Women With Breast Cancer. Start of enrollment: 1999 Feb 01
Terminated
A Phase III Randomized Trial Assessing the Utility of a Test Dose Program With Taxanes Start of enrollment: 2002 Jun 01
Completed
Phase 3
Dysregulated Tyrosine Kinase Signaling in Leukemia Start of enrollment: 2002 May 01
Terminated
Phase I-II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer Start of enrollment: 2000 May 01
Completed
Phase 1, Phase 2
Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer Start of enrollment: 2008 Feb 01
Active, not recruiting
Phase 3
Biomarker Study of Neoadjuvant Vitamin E in Patients With Locally Treatable Prostate Cancer Start of enrollment: 2008 Sep 01
Terminated
Phase 3
A Study of Imatinib and Valproic Acid in Patients With Chronic Myelogenous Leukemia (CML) Start of enrollment: 2009 Sep 01
Withdrawn
Phase 2
Phase I Trial of Everolimus, Pomalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma Start of enrollment: 2014 Jul 01
Terminated
Phase 1
Compassionate Use of BYL 719 Alpelisib
No longer available
Join now to see all

Publications & Presentations

PubMed

1 citations
The inflammatory response of human pancreatic cancer samples compared to normal controls.
Kathryn J Brayer, Joshua A Hanson, Shashank Cingam, Cathleen Martinez, Scott A Ness, Ian Rabinowitz> ;Plos One. 2023 Jan 1
7 citations
Genomic landscape of lymphatic malformations: a case series and response to the PI3Kα inhibitor alpelisib in an-of-1 clinical trial.
Montaser F Shaheen, Julie Y Tse, Ethan S Sokol, Margaret Masterson, Pranshu Bansal, Ian Rabinowitz, Christy A Tarleton, Andrey S Dobroff, Tracey L Smith, Thèrése J Boc...> ;Elife. 2022 Jul 5
382 citations
First-Line Nivolumab Plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer (CheckMate 568): Outcomes by Programmed Death Ligand 1 and Tumor Mutational Burden as Bioma...
Neal Ready, Matthew D. Hellmann, Mark M. Awad, Gregory A. Otterson, Martin Gutierrez, Justin F. Gainor, Hossein Borghaei, Jacques Jolivet, Leora Horn, Mihaela Mates, J...> ;Journal of Clinical Oncology. 2019 Feb 20
2 citations
Transient monoclonal gammopathy induced by Candida fungemia
Joanna L. Conant, Ian Rabinowitz, Qian-Yun Zhang> ;Human Pathology. 2017 Nov 1
9 citations
Antioxidants Abrogate Alpha-Tocopherylquinone-Mediated Down-Regulation of the Androgen Receptor in Androgen-Responsive Prostate Cancer Cells
Alexandra M. Fajardo, Debra MacKenzie, Sarah L. Olguin, John K. Scariano, Ian Rabinowitz, Todd A. Thompson> ;Plos One. 2016 Mar 17
24 citations
A Phase I Protocol of Hydralazine and Valproic Acid in Advanced, Previously Treated Solid Cancers.
Julie E. Bauman, Monte Shaheen, Claire F. Verschraegen, Steven A. Belinsky, M. Houman Fekrazad, Fa-Chyi Lee, Ian Rabinowitz, Meera Ravindranathan, Dennie V. Jones> ;Translational Oncology. 2014 Jun 1
18 citations
Disease-specific survival for patients with multiple myeloma: significant improvements over time in all age groups.
Edward N. Libby, David A. Garcia, Dulcinea Quintana, M. Houman Fekrazad, Julie E. Bauman, Ala Ebaid, Robert Hromas, Ian Rabinowitz, Charles L. Wiggins> ;Leukemia & Lymphoma. 2014 Mar 4
7 citations
Sorafenib-Induced Grade Four Hepatotoxicity in a Patient with Recurrent Gastrointestinal Stromal Tumor (GIST): A Case Report and Review of Literature
Waheed Murad, Ian Rabinowitz, Fa-Chyi Lee> ;ACG Case Reports Journal. 2014 Jan 10
7 citations
A patient with chronic lymphocytic leukemia and acquired angioedema: correlation of clinical and biochemical response to CLL therapy
Ghulam Rehman Mohyuddin, Ian Rabinowitz> ;Ecancermedicalscience. 2013 Feb 14
1 citations
Aspirin reduced recurrence of venous thromboembolism (VTE) after a first-ever, unprovoked VTE
Ian Rabinowitz> ;Annals of Internal Medicine. 2012 Oct 16
16 citations
Anaplastic Large Cell Lymphoma Associated With Breast Implants
Shalini Ravi-Kumar, Omid Sanaei, Mohammad A. Vasef, Ian Rabinowitz, Mohammad Houman Fekrazad> ;World Journal of Plastic Surgery. 2012 Jan 15
12 citations
Durable complete remission of primary plasma cell leukemia with the bortezomib plus melphalan and prednisone (VMP) regimen.
Edward N. Libby, Dulcinea Candelaria-Quintana, Hayan Moualla, Maryam Abdul-Jaleel, Ian Rabinowitz> ;American Journal of Hematology. 2010 Sep 1
12 citations
A phase I study of flavopiridol in combination with gemcitabine and irinotecan in patients with metastatic cancer.
Houman M. Fekrazad, Claire F. Verschraegen, Melanie Royce, Harriet O. Smith, Fa-Chyi Lee, Ian Rabinowitz> ;American Journal of Clinical Oncology. 2010 Aug 1
4 citations
Dose of prophylactic platelet transfusions did not affect bleeding incidence or severity
Ian Rabinowitz> ;Annals of Internal Medicine. 2010 Jun 15
125 citations
Phase II, Randomized Trial to Compare Anastrozole Combined with Gefitinib or Placebo in Postmenopausal Women with Hormone Receptor–Positive Metastatic Breast Cancer
Massimo Cristofanilli, Vicente Valero, Aroop Mangalik, Melanie Royce, Ian Rabinowitz, Francis P. Arena, Joan Kroener, Elizabeth Curcio, Claire Watkins, Sarah S. Bacus,...> ;Clinical Cancer Research. 2010 Mar 15
68 citations
Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine.
David R. Czuchlewski, Monica Brackney, Christina Ewers, Jonaki Manna, M. Houman Fekrazad, Afton Martinez, Kurt B. Nolte, Brian Hjelle, Ian Rabinowitz, Brian R. Curtis,...> ;American Journal of Clinical Pathology. 2010 Mar 1
1 citations
Tumor MET expression may not predict the risk of venous thromboembolism in cancer patients.
Hamid Sayar, Jeffrey T. Bunning, Sang Joon Lee, Edward N. Libby, Ian Rabinowitz> ;Oncology Research. 2010 Jan 1
29 citations
Enhanced leukemia cell detection using a novel magnetic needle and nanoparticles
Jason E. Jaetao, Kimberly S. Butler, Natalie L. Adolphi, Debbie M. Lovato, H.C. Bryant, Ian Rabinowitz, Stuart S. Winter, Trace E. Tessier, Helen J. Hathaway, Christia...> ;Cancer Research. 2009 Nov 1
29 citations
A phase I and pharmacokinetic study of paclitaxel poliglumex and cisplatin in patients with advanced solid tumors
Claire F. Verschraegen, Keith M. Skubitz, Adil Daud, Andrzej P. Kudelka, Ian Rabinowitz, Cecilia Allievi, Amy J. Eisenfeld, Jack W. Singer, Fred B. Oldham> ;Cancer Chemotherapy and Pharmacology. 2009 Apr 1
9 citations
Interaction Between Statins and Rituximab in Non-Hodgkin's Lymphoma
Ian Rabinowitz> ;Journal of Clinical Oncology. 2008 Nov 20
4 citations
Phase II studies of antiangiogenic four drug regimens for the treatment of advanced renal cell carcinoma: FUNIL-retinoid and the FUNIL-thalidomide protocols
Alonso V. Pacheco, Kanwaldeep Kaur Rasila, Sang Joon Lee, Ian Rabinowitz, Laurence Elias, Fa-Chyi Lee, Claire F. Verschraegen> ;Urologic Oncology. 2008 Nov 1
A phase II multicenter, double-blind, randomized trial to compare anastrozole plus gefinitib with anastrozole plus placebo in postmenopausal women with hormone recepto...
Cristofanilli M, Valero V, Mangalik A, Rabinowitz I, Arena FP, Kroener JF, Curcio E, Watkins C, Magill P> ;J. Clin. Oncol.. 2008-05-20
Tumor c-MET expression does not predict the risk of venous thromboembolism in cancer patients.
Rabinowitz I, Sayar H, Bunning J, Bocklage T, Lee S, Libby E> ;J. Clin. Oncol.. 2008-05-20
Tolerability/safety of sunitinib (SU) on schedule 2/1 in combination with capecitabine (C) in patients (pts) with advanced solid tumors (STs): A phase I dose-finding s...
Chiorean EG, Sweeney CJ, Verschraegen CF, Lee FC, Jones SF, Rabinowitz I, Tye L, Bello A, Chao R, Burris HA> ;J. Clin. Oncol.. 2008-05-20
Phase I study of capecitabine (C) in combination with cisplatin (DDP) and irinotecan (IRI) in patients (pts) with advanced solid malignancies.
Sayar H, Verschraegen CF, Smith H, Rabinowitz I, Lee FC, Shen Z> ;J. Clin. Oncol.. 2008-05-20
Join now to see all

Press Mentions

Reader Responses: Should a Pregnant Patient with Hemochromatosis Receive Iron?September 1st, 2020
Colorectal Cancer Awareness MonthMarch 19th, 2018

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

Lovelace Medical CenterAlbuquerque, New Mexico
University of New Mexico HospitalsAlbuquerque, New Mexico
Gila Regional Medical CenterSilver City, New Mexico

IanRabinowitzMD

Dr. Rabinowitz is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Press Mentions

Professional Memberships

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.